Back

Viral infectivity in pediatric SARS-CoV-2 clinical samples does not vary by age

Schmidt, M. M.; Despres, H. W.; Shirley, D. J.; Bose, M. E.; McCaul, K. C.; Crothers, J. W.; Henrickson, K. J.; Lee, B.; Bruce, E. A.

2022-10-18 infectious diseases
10.1101/2022.10.17.22281193 medRxiv
Show abstract

During the early months of the SARS-CoV-2 pandemic, notable uncertainty emerged regarding the role of children in transmission dynamics 1. With time, it became more clear that children were susceptible to infection with SARS-CoV-2, but that the vast majority of children experienced mild symptoms with lower incidence of severe disease 2. This pattern remained consistent despite the later emergence of SARS-CoV-2 variants, including Delta and Omicron, even among children <5 ineligible for vaccination3. The relative lack of severe disease in the pediatric population raised questions regarding viral kinetics and infectivity in children versus adults.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.